Quentis Therapeutics inks $48 mln Series A

New York City-based Quentis Therapeutics, a biotech company that focuses on treating cancer patients, has raised $48 million in Series A funding. The investors included Versant Ventures, Polaris Partners, AbbVie Ventures, Taiho Pharmaceutical Co. Ltd, Yonghua Capital, Alexandria Venture Investments and New York Ventures, the investment arm of Empire State Development.

Source: Press Release